One analyst raised target to $25: Guggenheim Names Novavax (NVAX) its Best Idea
One analyst raised target to $25: Guggenheim Names Novavax (NVAX) its Best Idea
I hope no one had more than pocket change in this stock.
OUCH.
I have not recommended this stock here. I clearly stated the title as being my stock pick.
....
If I pick a stock then I have purchased it myself.What's the difference between recommending and it being your pick? I am confused.
If I pick a stock then I have purchased it myself.
If I recommend a stock, I am encouraging you to buy it.
Everyone needs to be aware of pump and dumps! I try and pump as much as I can, would do more but thought to keep this subtle....... .
Do as I say or do as I do?
In this case, hope you did neither.
I watch a small investment like FTR go up and down around the $5 mark. Pays a nice dividend. One day it may implode.
In general I put money into big companies that consistently raise dividend. Really boring stuff.
Yup, it was there at beginning of year. This is a spinoff from Verizon/Spinco, acquired in 2010. What could possibly go more wrong with a 10% dividend stock?FTR is down 2% today to about $4 on a 1% up day. Nice dividend, but their accounting practices are considered "aggressive." Watch yourself with that one.
One analyst raised target to $25: Guggenheim Names Novavax (NVAX) its Best Idea